Xencor, Inc. (XNCR)
NASDAQ: XNCR · IEX Real-Time Price · USD
23.63
-0.30 (-1.25%)
At close: May 2, 2024, 4:00 PM
23.89
+0.26 (1.10%)
Pre-market: May 3, 2024, 8:46 AM EDT

Xencor Revenue

In the year 2023, Xencor had annual revenue of $168.34M with 2.28% growth. Revenue in the quarter ending December 31, 2023 was $44.69M with 106.80% year-over-year growth.

Revenue (ttm)
$168.34M
Revenue Growth
+2.28%
P/S Ratio
8.65
Revenue / Employee
$601,207
Employees
280
Market Cap
1.46B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023168.34M3.76M2.28%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 201840.60M-5.55M-12.02%
Dec 31, 201746.15M-62.87M-57.67%
Dec 31, 2016109.02M81.26M292.70%
Dec 31, 201527.76M18.24M191.62%
Dec 31, 20149.52M-652.00K-6.41%
Dec 31, 201310.17M648.00K6.80%
Dec 31, 20129.52M2.68M39.06%
Dec 31, 20116.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.20B
Brookdale Senior Living 3.02B
Omnicell 1.15B
Pacira BioSciences 674.98M
NovoCure 509.34M
Kiniksa Pharmaceuticals 301.77M
Gyre Therapeutics 113.45M
4D Molecular Therapeutics 20.72M
Revenue Rankings